Walgreens Boots Alliance stock holds steady as earnings loom
Published on 08/22/2026 at 08:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Walgreens Boots Alliance, Inc. (US9314271019) stock is trading in a relatively stable range as of August 21, 2026, while investors weigh a market capitalization in the multi-billion dollar range against the company’s next earnings release.
The latest reported quarter, which ended within the past nine months relative to August 21, 2026, showed revenue in the tens of billions of dollars and comparable retail sales rising versus the same quarter a year earlier. Profit remained more pressured because restructuring charges and inflation-linked costs offset part of the top-line progress.
Earnings and margins
Recent reporting also points to modest revenue growth guidance for the current fiscal year, with adjusted earnings per share expected to improve as cost reductions and portfolio optimization filter through. That setup matters because the most recent quarter already showed the gap investors are watching: revenue increased year over year, but operating income and net income were mixed.
Analyst consensus for the current fiscal year leans toward low single-digit revenue growth and a year-on-year increase in adjusted earnings per share from a depressed base. That makes the next update less about headline sales and more about whether margin recovery is becoming visible in the numbers.
Strategy and peers
Walgreens Boots Alliance has continued to push a multi-year restructuring, including store closures and supply-chain efficiency work, with the aim of generating hundreds of millions of dollars in annualized savings once fully phased in. The company is also leaning harder into healthcare services, digital prescriptions, and in-store health offerings to reduce dependence on front-of-store retail.
For investors, the comparison that stands out is straightforward: Walgreens Boots Alliance was valued at $10.36 billion in August 2026, far below the $118.96 billion market cap shown for CVS Health in the same period. That gap reflects how much execution Walgreens still has to prove before the market is willing to re-rate the shares.
Consumer pharmacy model
A core part of the business is the neighborhood pharmacy network, which combines prescription filling, refills, immunizations, over-the-counter health items, and convenience retail under one roof. That model still gives Walgreens Boots Alliance reach across everyday consumer demand and basic healthcare services.
Stock snapshot
Walgreens Boots Alliance stock remains a large-cap U.S. healthcare and consumer name on Nasdaq as of August 21, 2026. The current valuation and the latest reported-quarter trends leave the market focused on whether the next earnings update can show better cash generation, improved margins, and more durable progress from the restructuring plan.
Company facts
Company: Walgreens Boots Alliance, Inc.
ISIN: US9314271019
Ticker: WBA
Exchange: Nasdaq
Sector / Industry: Consumer staples / Drug retail
Index membership: S&P 500
